Skip to content
★ Sign in to follow
MK

Mohamed Khairie Issa

Executive
Insider activity · 24 months0 buys1 saleCumulative net flow
Total declarations
8
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€1.1M

Latest filing published 20 Jul 2026 for INCYTE CORP, €110k.

Filing timeline

BuySale
Mohamed Khairie Issa

Insider track record

Disclosed buys
0
Disclosed sells
2

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Mohamed Khairie Issa: trading record in brief

Mohamed Khairie Issa discloses dealings in Incyte Corp to SEC (Form 4). Between 6 January 2025 and 16 July 2026, the trades on record add up to 8 filings.

On the market, this insider has only sold: 2 sales, €1.1M in total. The rest of the record consists of 6 share grants. Since January 2026: no purchases and 2 sales on the market.

Most recently, on 20 July 2026, the filings show a share grant in Incyte Corp. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Mohamed Khairie Issa

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▼
    EVP, Head of U.S. CommercialExecutivesIncyte Corp
    125,706 USD0SEC
    1,093 shares@ US$115.01Common StockSEC:0002050035-26-000011:0
  • ◆
    EVP, Head of U.S. CommercialExecutivesIncyte Corp
    0SEC
    7,857 shares0Common StockSEC:0002050035-26-000011:1
  • ◆
    EVP, Head of U.S. CommercialExecutivesIncyte Corp
    126,484 USD18SEC
    1,099 shares@ US$115.090.0005% mcap12.8% of flowCommon StockSEC:0002050035-26-000009:0
  • ◆
    EVP, Head of US OncologyExecutivesIncyte Corp
    881,438 USD19SEC
    8,264 shares@ US$106.66100.0% of flowCommon StockSEC:0002050035-26-000002:0
  • ◆
    EVP, Head of US OncologyExecutivesIncyte Corp
    0SEC
    8,769 shares0Common StockSEC:0000879169-25-000090:0
  • ◆
    EVP, Head of US OncologyExecutivesIncyte Corp
    0SEC
    27,812 shares0Common StockSEC:0000879169-25-000068:0
  • ◆
    EVP, Head of US OncologyExecutivesIncyte Corp
    0SEC
    48,671 shares0Common StockSEC:0000879169-25-000009:0

7 of 7 declarations